Skip to content

The Effect of Antihypertensive Agents Concerning With Hemodynamics and Reduction of Anaesthetics in Orthognathic Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01839253
Enrollment
75
Registered
2013-04-24
Start date
2012-08-31
Completion date
2014-03-31
Last updated
2014-04-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Orthognathic Surgery

Keywords

antihypertensive agents, hemodynamic, anesthetics reduction, orthognathic surgery

Brief summary

For those who receive hypotensive anesthesia in orthognathic surgeries, the investigators premedicate with anti-hypertensive agent so that it decreases the occurence of tachycardia and the rebound hypertension due to hypotensive anesthesia, enabling us to compare hemodynamic stability and reduction of anesthetic agents during the operation.

Interventions

DRUGb-blocker(Atenolol)
DRUGACE inhibitor(Enapril)
OTHERcontrol

Sponsors

Yonsei University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 29 Years
Healthy volunteers
No

Inclusion criteria

1. ASA class I-II 2. obtaining written informed consent from the parents 3. aged 18-29 years who were undergoing orthognathic surgery.

Exclusion criteria

1. Hypertension patients with anti-hypertensive agents 2. chronic renal failure or End stage renal disease patients. 3. renal artery stenosis history. 4. Patients who are with medication due to systemic disease. 5. symptomatic asthma 6. Drug hyperactivity 7. neurological or psychiatric illnesses 8. mental retardation 9. patients who can't read the consent form due to illiterate or foreigner

Design outcomes

Primary

MeasureTime frameDescription
the influence of antihypertensive agents on hemodynamic stabilityFrom the beginning until the end of hypoetensive anesthesiaan expected average of 65 mins.(From manipulration of Mandible to maxilla)Total minutes when the MAP is lower than 55mmHg and higher than 65mmHg (min) , The time below 55 mmHg(min) , The total time above 65 mmHg (min) Total remifentanil amount, total NTG amount, total phenylephrine amount Arterial gas analysis 4 times after induction, at the start of manipulation of mandible, at the start of manipulation of maxilla, at the end of surgery. Pr-operative and post-operative lab (Hb, Bun, Cr, OT, PT, Na, K) Intraoperative total fluid, total urine amount, total blood loss, transfusion amount.

Secondary

MeasureTime frameDescription
reduction of anaesthetics with controlFrom the beginning until the end of hypoetensive anesthesia an expected average of 65 mins.(From manipulration of Mandible to maxilla)Total minutes when the MAP is lower than 55mmHg and higher than 65mmHg (min) , The time below 55 mmHg(min) , The total time above 65 mmHg (min) Total remifentanil amount, total NTG amount, total phenylephrine amount Arterial gas analysis 4 times after induction, at the start of manipulation of mandible, at the start of manipulation of maxilla, at the end of surgery. Pr-operative and post-operative lab (Hb, Bun, Cr, OT, PT, Na, K) Intraoperative total fluid, total urine amount, total blood loss, transfusion amount.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026